title: Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
authors.affiliation: Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. scome@caregroup.harvard.edu
authors.forename: Steven E
authors.initials: SE
authors.lastname: Come
authors.forename: Aman U
authors.initials: AU
authors.lastname: Buzdar
authors.forename: Carlos L
authors.initials: CL
authors.lastname: Arteaga
authors.forename: Angela M
authors.initials: AM
authors.lastname: Brodie
authors.forename: Nancy E
authors.initials: NE
authors.lastname: Davidson
authors.forename: Mitch
authors.initials: M
authors.lastname: Dowsett
authors.forename: James N
authors.initials: JN
authors.lastname: Ingle
authors.forename: Stephen R D
authors.initials: SR
authors.lastname: Johnston
authors.forename: Adrian V
authors.initials: AV
authors.lastname: Lee
authors.forename: C Kent
authors.initials: CK
authors.lastname: Osborne
authors.forename: Kathleen I
authors.initials: KI
authors.lastname: Pritchard
authors.forename: Victor G
authors.initials: VG
authors.lastname: Vogel
authors.forename: Eric P
authors.initials: EP
authors.lastname: Winer
authors.forename: Carol S
authors.initials: CS
authors.lastname: Hart
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D005260:Female; D005544:Forecasting; D006801:Humans; D009376:Neoplasms, Hormone-Dependent
chemical_list: D018931:Antineoplastic Agents, Hormonal